| Net Cash Provided by (Used in) Operating Activities |
-418M |
USD |
-190% |
Q1 2025 |
Q1 2025 |
| Net Cash Provided by (Used in) Financing Activities |
594M |
USD |
|
Q1 2025 |
Q1 2025 |
| Common Stock, Shares Authorized |
750M |
shares |
0% |
Q3 2025 |
Q3 2025 |
| Common Stock, Shares, Issued |
280M |
shares |
0% |
Q3 2025 |
Q3 2025 |
| Common Stock, Par or Stated Value Per Share |
0 |
USD/shares |
0% |
Q3 2025 |
Q3 2025 |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect |
176M |
USD |
+1500% |
Q1 2025 |
Q1 2025 |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents |
155M |
USD |
-58.2% |
Q3 2025 |
Q3 2025 |
| Interest Paid, Excluding Capitalized Interest, Operating Activities |
151M |
USD |
+26.9% |
Q1 2025 |
Q1 2025 |
| Preferred Stock, Shares Issued |
0 |
shares |
|
Q3 2025 |
Q3 2025 |
| Preferred Stock, Shares Authorized |
50M |
shares |
0% |
Q3 2025 |
Q3 2025 |
| Additional Paid in Capital |
9.28B |
USD |
-1.62% |
Q3 2025 |
Q3 2025 |
| Preferred Stock, Shares Outstanding |
0 |
shares |
|
Q3 2025 |
Q3 2025 |
| Interest Expense |
469M |
USD |
+16.7% |
Q1 2024 |
Q1 2024 |
| Preferred Stock, Par or Stated Value Per Share |
0 |
USD/shares |
0% |
Q3 2025 |
Q3 2025 |